P S Kulkarni

Summary

Publications

  1. ncbi request reprint No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study
    P S Kulkarni
    Serum Institute of India Ltd, 212 2 Hadapsar, Pune 411028, India
    Vaccine 23:5286-8. 2005
  2. pmc Diphtheria, tetanus, and pertussis immunity in Indian adults and immunogenicity of td vaccine
    Prasad S Kulkarni
    Clinical Department, Serum Institute of India Ltd, 212 2, Hadapsar, Pune 411028, India
    ISRN Microbiol 2011:745868. 2011
  3. doi request reprint Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers
    Prasad S Kulkarni
    Serum Institute of India Ltd, Hadapsar, Pune, India
    Vaccine 31:2719-22. 2013
  4. pmc A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac (®) ) in India
    Prasad S Kulkarni
    Serum Institute of India Ltd, Pune, India
    Hum Vaccin Immunother 9:122-4. 2013
  5. doi request reprint Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children
    Prasad S Kulkarni
    Serum Institute of India Ltd, Pune, India
    Vaccine 31:20-2. 2012
  6. ncbi request reprint Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults
    P S Kulkarni
    Serum Institute of India Ltd, 212 2, Hadapsar, Pune 411028, India
    Vaccine 24:3457-60. 2006
  7. ncbi request reprint Immunogenicity of two modern tissue culture rabies vaccines in pre-exposure prophylaxis
    P S Kulkarni
    Serum Institute of India Ltd, Pune, India
    Hum Vaccin 3:183-6. 2007
  8. doi request reprint Immunogenicity of two diphtheria-tetanus-whole cell pertussis-hepatitis B vaccines in infants: a comparative trial
    Prasad S Kulkarni
    Serum Institute of India Ltd 212 2, Hadapsar, Pune, India
    Hum Vaccin 7:941-4. 2011
  9. pmc Persistence of antibodies induced by measles-mumps-rubella vaccine in children in India
    S K Raut
    Serum Institute of India Ltd, Pune, 212 2, Hadapsar, India
    Clin Vaccine Immunol 14:1370-1. 2007
  10. ncbi request reprint Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study
    Amita Sapru
    King Edward Memorial Hospital and Research Centre, Pune, India
    J Trop Pediatr 53:303-7. 2007

Collaborators

  • Suresh S Jadhav
  • M A Phadke
  • Amita Sapru
  • S K Raut
  • - Shivananda
  • S V Kapre
  • Sheila Bhave
  • S R Godse
  • S P Dhorje
  • Ashish Bavdekar
  • Anand N Pandit
  • S S Naik
  • R M Dhere
  • M Mohan
  • Virbhadra Somani
  • B S Srikanth
  • P S Patki

Detail Information

Publications13

  1. ncbi request reprint No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study
    P S Kulkarni
    Serum Institute of India Ltd, 212 2 Hadapsar, Pune 411028, India
    Vaccine 23:5286-8. 2005
    ..Isolation of the vaccine virus is necessary for definite causal association of AM with the vaccine. There is no such evidence to causally link MMR vaccine containing L-Zagreb mumps strain with AM...
  2. pmc Diphtheria, tetanus, and pertussis immunity in Indian adults and immunogenicity of td vaccine
    Prasad S Kulkarni
    Clinical Department, Serum Institute of India Ltd, 212 2, Hadapsar, Pune 411028, India
    ISRN Microbiol 2011:745868. 2011
    ..There is need of three doses of Td vaccination in those Indian adults, who missed their primary immunization. Susceptibility to pertussis also needs to be further explored...
  3. doi request reprint Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers
    Prasad S Kulkarni
    Serum Institute of India Ltd, Hadapsar, Pune, India
    Vaccine 31:2719-22. 2013
    ..We have developed a new purified vero cell rabies vaccine (PVRV) and evaluated its safety and immunogenicity in healthy volunteers by intramuscular (IM) and intradermal (ID) routes of vaccination...
  4. pmc A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac (®) ) in India
    Prasad S Kulkarni
    Serum Institute of India Ltd, Pune, India
    Hum Vaccin Immunother 9:122-4. 2013
    ..65%). The reactions included mild to moderate respiratory symptoms. No H1N1 case was encountered during one year postvaccination. The data show the safety of the live attenuated influenza vaccine platform developed in India...
  5. doi request reprint Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children
    Prasad S Kulkarni
    Serum Institute of India Ltd, Pune, India
    Vaccine 31:20-2. 2012
    ..The overall seroprotection was 96% and 89% with 10 and 15 μg doses, respectively, while the seroconversion was 92% and 88%. The new Indian-made pandemic H1N1 vaccine is safe and immunogenic in adults and children above 3 years of age...
  6. ncbi request reprint Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults
    P S Kulkarni
    Serum Institute of India Ltd, 212 2, Hadapsar, Pune 411028, India
    Vaccine 24:3457-60. 2006
    ..vaccine is developed using Hansenula polymorpha yeast. We decided to assess the immunogenicity, and reactogenicity of this vaccine in a large adult population...
  7. ncbi request reprint Immunogenicity of two modern tissue culture rabies vaccines in pre-exposure prophylaxis
    P S Kulkarni
    Serum Institute of India Ltd, Pune, India
    Hum Vaccin 3:183-6. 2007
    ..With HDC vaccines, cost has been an issue. However, since the new HDC vaccine has a comparable cost to the CEC vaccine, it may be possible to use it in large-scale vaccinations...
  8. doi request reprint Immunogenicity of two diphtheria-tetanus-whole cell pertussis-hepatitis B vaccines in infants: a comparative trial
    Prasad S Kulkarni
    Serum Institute of India Ltd 212 2, Hadapsar, Pune, India
    Hum Vaccin 7:941-4. 2011
    ..We compared immunogenicity and reactogenicity of two tetravalent vaccines in Indian children, who after neonatal HB immunization, were vaccinated thrice with one of these vaccines...
  9. pmc Persistence of antibodies induced by measles-mumps-rubella vaccine in children in India
    S K Raut
    Serum Institute of India Ltd, Pune, 212 2, Hadapsar, India
    Clin Vaccine Immunol 14:1370-1. 2007
    ..The MMR vaccine induces long-term immunity in a majority of vaccinees; however, due to the observation of some seronegative vaccinees, the policy of administering a second dose of the MMR vaccine seems appropriate...
  10. ncbi request reprint Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study
    Amita Sapru
    King Edward Memorial Hospital and Research Centre, Pune, India
    J Trop Pediatr 53:303-7. 2007
    ..Adverse events were similar in both vaccine groups. Immunogenicity and reactogenicity of the Indian and European Hepatitis B vaccines were comparable, when immunization was started at birth...
  11. pmc Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India
    - Shivananda
    Indira Gandhi Institute of Child Health, Bangalore, India
    Clin Vaccine Immunol 13:661-4. 2006
    ..Reactogenicity was similar for the two vaccines. The present study shows that GeneVac-B is as immunogenic and as well tolerated as Engerix-B when administered with DTPw vaccine at 6, 10, and 14 weeks of age...
  12. ncbi request reprint Pharmacovigilance on MMR vaccine containing L-Zagreb mumps strain
    M A Phadke
    Vaccine 22:4135-6. 2004